Ignite Creation Date:
2025-12-25 @ 1:34 AM
Ignite Modification Date:
2026-02-22 @ 5:08 PM
Study NCT ID:
NCT04000594
Status:
COMPLETED
Last Update Posted:
2024-10-03
First Post:
2019-06-26
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Investigate the Pharmacokinetics and Pharmacodynamics of RO7234292 (RG6042) in CSF and Plasma, and Safety and Tolerability Following Intrathecal Administration in Patients With Huntington's Disease
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-09-02
Start Date Type:
ACTUAL
Primary Completion Date:
2022-01-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-01-18
Completion Date Type:
ACTUAL
First Submit Date:
2019-06-26
First Submit QC Date:
None
Study First Post Date:
2019-06-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-01-13
Results First Submit QC Date:
None
Results First Post Date:
2024-10-03
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-06-18
Last Update Post Date:
2024-10-03
Last Update Post Date Type:
ACTUAL